XETR
LXS
Market cap1.25bUSD
Oct 09, Last price
12.69EUR
1D
1.68%
1Q
-15.40%
Jan 2017
-79.65%
IPO
-64.34%
Name
Lanxess AG
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
LANXESS AG is a global producer and supplier of a diverse range of specialized chemical products, encompassing chemical intermediates, various additives, distinct specialty chemicals, and advanced plastics. The company's operations are strategically organized into four distinct divisions: Advanced Intermediates, Specialty Additives, Consumer Protection, and Engineering Materials. The Advanced Intermediates division delivers sophisticated industrial building blocks, fundamental and specialized chemical compounds, organometallic substances, and mineral-based pigments. These offerings serve a broad spectrum of sectors, including agriculture, automotive manufacturing, building and construction, fragrances and food additives, semiconductor and solar energy production, and the color pigment industry. Within the Specialty Additives segment, LANXESS provides an array of performance-enhancing additives. This portfolio includes lubricants, fire retardants, plasticizing agents, and bromine-derived compounds, which find extensive use in applications across the rubber, plastics, coatings, construction, and electrical sectors. The Consumer Protection division focuses on solutions for safeguarding materials, along with disinfectant, sanitation, and preservation agents. It also supplies flavors and scents, as well as crucial precursors and intermediates for the agrochemical, pharmaceutical, and specialty chemical industries. Furthermore, this segment offers advanced technologies for purifying water and other liquid substances. The Engineering Materials segment is responsible for manufacturing high-performance technical plastics, glass fibers, composite materials, and urethane-based elastomers. These advanced materials are vital for applications in the automotive, electrical and electronics, construction, and medical industries, as well as in the sports and recreation markets. Established in 1863, the company maintains its corporate headquarters in Cologne, Germany.
Related entities
Subsidiaries (34)
LANXESS Organometallics GmbH
LANXESS PTE. LTD.
LANXESS PTY LTD
LANXESS S.A. de C.V.
LANXESS S.R.L.
LANXESS Sales Netherlands B.V.
LANXESS Solutions Australia Pty. Ltd.
LANXESS SOLUTIONS INDIA PRIVATE LIMITED
LANXESS SOLUTIONS ITALY S.R.L.
LANXESS SOLUTIONS UK LTD
LANXESS Switzerland GmbH
LANXESS URETHANES UK LTD
N&H International Holding 3 B.V.
SALTIGO GmbH
Key people
Chairman of the Management Board, Chief Executive Officer · since 2014
Birgit Bierther
Vice Chairman of the Supervisory Board, Employee Representative · since 2019
Gisela Seidel
Vice Chairwoman of the Supervisory Board, Employee Representative · since 2015
Stephanie Cossmann
Member of the Management Board, Labor Relations Director · since 2020
Pamela Knapp
Independent Member of the Supervisory Board · since 2018
Theo H. Walthie
Independent Member of the Supervisory Board · since 2010
Headquarters & legal address
Kennedyplatz 1
Köln, NW 50569
DE
Köln, NW 50569
DE
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||